No abstract

No abstract

No abstract

One current view of schizophrenia is that its clinical and functional features show a deteriorating course, particularly for negative symptoms. However, this is difficult to study in chronic patients who have been exposed to pharmacologic treatment and institutionalization. Examining first-episode (FE) patients can help clarify which symptoms are present initially and how the symptom pattern is linked to functioning. We evaluated a sample of 37 FE patients with schizophrenia and compared them to 70 other schizophrenia (OS) patients on standard clinical scales, measures of premorbid functioning, and quality of life. FE patients showed a symptom profile similar to OS patients; in particular, there was no evidence that negative symptoms are less severe in the FE group. Analysis of the clinical data led us to the conclusion that the symptom profile of schizophrenia exists at the outset, that negative symptoms are associated with poor premorbid and current functioning, but that the role of positive symptoms is more complex and may vary in subtypes.

No abstract

No abstract

This study examined patients with schizophrenic disorders treated with clozapine in a state hospital setting. Gender and diet affected weight gain over a six-month period. Pre-treatment weight status also related to eventual weight gain. There were no significant effects of dosage. Weight gain was most pronounced in non-dieting women. This has implications for management of patients on clozapine

No abstract